Cabozantinib in Advanced Prostate Cancer: Is the Therapeutic Window Too Narrow?
09:18 Share

This podcast discusses a phase 2 trial of cabozantinib in men with advanced bone-metastatic prostate cancer, using a novel method to assess bone scan response.